Microbot Medical Inc. announced it will present recent commercial achievements and the Full Market Release of its LIBERTY Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference on April 15, 2026.
Key takeaways
Company issued press release announcing presentation at Needham Healthcare Conference on April 15, 2026 at 10:15 a.m. ET by CEO Harel Gadot.
Highlighting recent commercial achievements leading to Full Market Release (FMR) of LIBERTY Endovascular Robotic System.
LIBERTY is FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures.
Recently completed limited market release and commenced full market release in U.S. at SIR Annual Scientific Meeting.
Presentation webcast live via Investors section at https://ir.microbotmedical.com/.
Team to meet institutional investors in one-on-one meetings at the conference.